Drug-delivery innovation headlines this industry update, offering a look at recent biotech moves toward oral treatment approaches for metabolic disorders.
Key Takeaways
- Rani Therapeutics will collaborate with PegBio to develop oral formulations for obesity molecules
- RaniPill formulations will be assessed in preclinical work to select clinical candidates
- Rani's preclinical oral candidates showed pharmacokinetics and weight loss comparable to injections